Surgical oncology and reconstruction
Elective Neck Dissection Versus Wait-and-Watch Policy for Oral Cavity Squamous Cell Carcinoma in Early Stage: A Systematic Review and Meta-Analysis Based on Survival Data

https://doi.org/10.1016/j.joms.2019.03.015Get rights and content

Purpose

Whether elective neck dissection (END) should be adopted for patients with clinically early-stage (cT1-2N0M0) oral cavity squamous cell carcinoma (OCSCC) remains debated. The aim of this systematic review was to compare the survival benefit of END with that of the wait-and-watch policy (WW) for patients with early-stage OCSCC based on survival data.

Materials and Methods

According to the inclusion criteria, an exhaustive search for eligible studies was conducted. The study inclusion and data extraction were performed by 2 reviewers independently. The risk of bias was assessed in duplicate using the Risk Of Bias In Nonrandomized Studies of Interventions instrument. The hazard ratio (HR) of the time-to-event data was extracted or estimated. RevMan 5.3 and STATA 15.1 were adopted for data synthesis.

Results

Of the 35 studies that were included, only 5 were assessed as having a low risk of bias. Results of the meta-analyses showed END could significantly decrease neck recurrence (relative risk = 0.45; confidence interval [CI], 0.35-0.59; P < .00001) and improve disease-free survival (HR = 0.55; CI, 0.42-0.71; P < .00001), overall survival (HR = 0.75; CI, 0.64-0.86; P < .0001), and disease-specific survival (HR = 0.76; CI, 0.61-0.94; P = .01) compared with WW for patients with cT1-2N0. The subgroup analysis showed that END could decrease neck recurrence (P < .00001) and improve disease-free survival (P = .001) for patients with early-stage tongue cancer and that supraomohyoid neck dissection could decrease neck recurrence (P = .02). For patients with cT1N0, END could significantly decrease the proportion with neck recurrence (P = .0008) and improve disease-free survival (P = .0003), but the difference between overall survival and disease-specific survival did not achieve significance.

Conclusions

END can decrease recurrence and improve survival time for patients with early-stage OCSCC. More high-quality studies are needed to make a solid conclusion, especially for patients with cT1N0M0.

Section snippets

Materials and Methods

A protocol specifying the review method was established in advance. Two reviewers conducted the study inclusion, data extraction, and quality assessment independently and in duplicate. Any discrepancies were resolved through discussion.

Search Result

The search retrieved 3,860 search records. Sixty publications were evaluated as eligible after screening. After further evaluation of full texts, 20 publications were excluded for reasons listed in Supplement 3. Data from 5 publications overlapped with 5 other publications listed in Supplement 4; thus, these were regarded as only 5 studies. In total, 35 studies were included in this systematic review.3, 6, 7, 8, 9, 10, 11, 12, 13, 14, 17, 18, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39,

Discussion

Once cervical lymph nodes are found to be metastatic during follow-up, salvage neck dissection cannot always save the patient and sometimes the salvage rate is lower than 40%.50 In some cases, prophylactic neck dissection was conducted simultaneously with ablation of the primary lesion to remove occult metastatic cervical lymph nodes. Notably, occult metastatic lymph nodes do not present in all patients with a clinically N0 neck; thus, some researchers believe END is unnecessary for patients

References (74)

  • Z. Feng et al.

    Elective neck dissection versus observation in the management of early tongue carcinoma with clinically node-negative neck: A retrospective study of 229 cases

    J Craniomaxillofac Surg

    (2014)
  • D. Franceschi et al.

    Improved survival in the treatment of squamous carcinoma of the oral tongue

    Am J Surg

    (1993)
  • M. Goto et al.

    Prognostic significance of late cervical metastasis and distant failure in patients with stage I and II oral tongue cancers

    Oral Oncol

    (2005)
  • N. Kelner et al.

    Does elective neck dissection in T1/T2 carcinoma of the oral tongue and floor of the mouth influence recurrence and survival rates?

    Br J Oral Maxillofac Surg

    (2014)
  • J. Kligerman et al.

    Supraomohyoid neck dissection in the treatment of T1/T2 squamous cell carcinoma of oral cavity

    Am J Surg

    (1994)
  • T.R. Liu et al.

    Elective neck dissection in clinical stage I squamous cell carcinoma of the tongue: Does it improve regional control or survival time?

    Oral Oncol

    (2011)
  • G.D. Orabona et al.

    Neck dissection versus “watchful-waiting” in early squamous cell carcinoma of the tongue our experience on 127 cases

    Surg Oncol

    (2016)
  • K.A. Peng et al.

    Is there a role for neck dissection in T1 oral tongue squamous cell carcinoma? The UCLA experience

    Am J Otolaryngol Head Neck Med Surg

    (2014)
  • P. Piedbois et al.

    Stage I-II squamous cell carcinoma of the oral cavity treated by iridium-192: Is elective neck dissection indicated?

    Radiother Oncol

    (1991)
  • T. Zhang et al.

    Treatment of cT1N0M0 tongue cancer: Outcome and prognostic parameters

    J Oral Maxillofac Surg

    (2014)
  • S. Spalthoff et al.

    Neck dissection’s burden on the patient: Functional and psychosocial aspects in 1,652 patients with oral squamous cell carcinomas

    J Oral Maxillofac Surg

    (2017)
  • Y. Shibuya et al.

    Oral squamous cell carcinoma with microscopic extracapsular spread in the cervical lymph nodes

    Int J Oral Maxillofac Surg

    (2014)
  • R. Dirven et al.

    Tumor thickness versus depth of invasion—Analysis of the 8th edition American Joint Committee on Cancer Staging for oral cancer

    Oral Oncol

    (2017)
  • C.T. Liao et al.

    Good tumor control and survivals of squamous cell carcinoma of buccal mucosa treated with radical surgery with or without neck dissection in Taiwan

    Oral Oncol

    (2006)
  • L.Z. Liang et al.

    Selective versus comprehensive neck dissection in patients with T1 and T2 oral squamous cell carcinoma and cN0pN(+) neck

    J Oral Maxillofac Surg

    (2016)
  • S.F. Fan et al.

    Sentinel lymph node biopsy versus elective neck dissection in patients with cT1-2N0 oral tongue squamous cell carcinoma

    Oral Surg Oral Med Oral Pathol Oral Radiol

    (2014)
  • I. Ganly et al.

    Early stage squamous cell cancer of the oral tongue—Clinicopathologic features affecting outcome

    Cancer

    (2012)
  • Y.C. Lim et al.

    Treatment of contralateral N0 neck in early squamous cell carcinoma of the oral tongue: Elective neck dissection versus observation

    Laryngoscope

    (2006)
  • A.K. D’Cruz et al.

    Elective neck dissection for the management of the N0 neck in early cancer of the oral tongue: Need for a randomized controlled trial

    Head Neck

    (2009)
  • A.K. D’Cruz et al.

    Elective versus therapeutic neck dissection in node-negative oral cancer

    N Engl J Med

    (2015)
  • A. Ebrahimi et al.

    Improved survival with elective neck dissection in thick early-stage oral squamous cell carcinoma

    Head Neck

    (2012)
  • K.J. Haddadin et al.

    Improved survival for patients with clinically T1/T2, N0 tongue tumors undergoing a prophylactic neck dissection

    Head Neck

    (1999)
  • S.F. Huang et al.

    The role of elective neck dissection in early stage buccal cancer

    Laryngoscope

    (2015)
  • D. Mirea et al.

    Elective neck dissection in patients with stage T1-T2N0 carcinoma of the anterior tongue

    Hippokratia

    (2014)
  • A.P.W. Yuen et al.

    Elective neck dissection versus observation in the treatment of early oral tongue carcinoma

    Head Neck

    (1997)
  • A.P. Yuen et al.

    Prospective randomized study of selective neck dissection versus observation for N0 neck of early tongue carcinoma

    Head Neck

    (2009)
  • T. Imai et al.

    Retrospective observational study of occult cervical lymph-node metastasis in T1N0 tongue cancer

    Jpn J Clin Oncol

    (2017)
  • Cited by (22)

    View all citing articles on Scopus

    Yubin Cao and Tao Wang contributed equally to this work.

    This research is funded by the Health Bureau of Sichuan (18PJ094).

    Conflict of Interest Disclosures: None of the authors have any relevant financial relationship(s) with a commercial interest.

    View full text